Cardiogramme
Logo   Accueil | Table des matières | Téléchargements | Liens |   Mentions légales   | Contact |Abréviations
Logo  

Bibliographie

Lectures conseillées

FERRARIS VA, BROWN JR, DESPOTIS GJ, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91:944-82
GOODNOUGH LT, LEVY JH, MURPHY MF. GOODNOUGH LT. Blood transfusion 1. Concepts of blood transfusion in adults. Lancet 2013; 381:1845-54
KOZEK-LANGENECKER SA, AFSHARI A, ALBALADEJO P, et al. Management of severe perioperative bleeding. Guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30:270-382
NALLA BP, FREEDMAN J, HARE GMT, MAZER CD. Update on blood conservation for cardiac surgery. J Cardiothorac Vasc Anesth 2012; 26:117-33
NAPOLITANO LM, KUREK S, LUCHETTE FA, et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med 2009; 37:3124-57
SHANDER A, JAVIDROOZI M, OZAWA S, HARE GMT. What is really dangerous: anaemia or transfusion ? Br J Anaesth 2011; 107(S1):i41-i59
SPAHN DR, GOODNOUGH LT. Blood transfusion 2. Alternatives to blood transfusion. Lancet 2013; 381:1855-65
THEUSINGER OM, FELIX C, SPAHN DR. Strategies to reduce the use of blood products: a European perspective. Curr Opin Anaesthesiol 2012; 25:59-65

 

Références

1 AKOWUAH E, SHRIVASTAVA V, JAMNADAS B, et al. Comparison of two strategies for the management of antiplatelet therapy during urgent surgery. Ann Thorac Surg 2005; 80:149-52
2 ALDERMAN EL, LEVY JH, RICH JB, et al. Analyses of coronary graft patency after aprotinin use: results from the international multicenter aprotinin graft patency experience trial. J Thorac Cardiovasc Surg 1998; 116:716-30
2a ALFIREVIC A, DUNCAN A, YOU J, et al. Recombinant factor VII is associated with worse survival in complex cardiac surgical patients. Ann Thorac Surg 2014; 98:618-24
3 ALLAIN JP, CANDOTTI D, SOLDAN K et al. The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood 2003; 101:2419-25
3a ALSALEH K, ALOTAIBI GS, ALMODAIMEGH HS, et al. The use of preoperative erythropoiesis-stimulating agents (ESAs) in patients who underwent knee or hip arthroplasty: a meat-analysis of randomised clinical trials. J Arthroplasty 2013; 28:1463-72
4 ALSTRÖM U, LEVIN LA, STÅHLE A, et al. Cost analysis of re-exploration for bleeding after coronary artery bypass graft surgery. Br J Anaesth 2012; 108:216-22
5 ALVAREZ GG, FERGUSSON DA, NEILIPOVITZ DT, HEBERT PC. Cell salvage does not minimize perioperative allogeneic blood transfusion in abdominal vascular surgery: a systematic review. Can J Anaesth 2004; 51:425-31
6 AL-ZIRQI I, VANGEN S, FORSEN L, et al. Prevalence and risk factors of severe obstetric haemorrhage. Br J Obst Gynecol 2008; 115:1265-72
7 AMATO AC, PESCATORI M. Effect of perioperative blood transfusion on recurrence of colorectal cancer: Meta-analysis stratified on risk factors. Dis Colon Rectum 1998; 41:570-85
8 ATZIL S, ARAD M, GLASNER A, et al. Blood transfusion promotes cancer progression: A critical role for aged erythrocytes. Anesthesiology 2008; 109:989-7
8a BARON DM, HOCHRIESER H, POSCH M, et al. Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients. Br J Anaesth 2014; 113:416-23
9 BASRAN S, FRUMENTO RJ, COHEN A, et al. The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery. Anesth Analg 2006; 103:15-20
10 BENEDETTO U, LUCIANI R, GORACCI M, et al. Miniaturized cardiopulmonary bypass and acute kidney injury in coronary artery bypass graft surgery. Ann Thorac Surg 2009; 88:529-35
11 BERIS P. The use of iron to increase red cell mass. Can J Anaesth 2003; 50:S3-9
12 BERNARD AC, DAVENPORT DL, CHANG PK, et al. Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg 2009; 208:931-7
12a BEYER-WESTENDORF J, GELBRICHT V, FORSTER K, et al. Peri-interventional management of novel oral anticoagulants in daily care : results from prospective Dresden NOAC registry. Eur Heart J 2014 ; 35:1888-96
13 BILGIN YM, VAN DE WATERING LMG, EIJSMAN L, et al. Double-blind, randomized controlled trial on the effect of leucocyte-depleted erythrocyte transfusions in cardiac-valve surgery. Circulation 2004; 109:2755-60
14 BOLLIGER D, GÖRLINGER K, TANAKA KA. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 2010; 113:1205-19
14a BOLLIGER D, MAUERMANN E, TANAKA KA. Thresholds for perioperative administration of hemostatic blood components and coagulation factore concentrates: an unmet medical need. J Cardiothorac Vasc Anesth 2015; 29:768-76
15 BOODHWANI M, WILLIAMS K, BABAEV K, et al. Ultrafiltration reduces blood transfusions following cardiac surgery: A meta-analysis. Eur J Cardiothorac Surg 2006; 30:892-7
16 British Committee for Standards in Haematology: Guidelines for the use of platelet transfusions. Br J Haematol 2003; 122:10-23
17 BROWN JR, BIRKMEYER NJO, O’CONNOR GT. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation 2007 ; 115 :2801-13
18 CARLIER M, VO MAI MP, FAUVEAU I, et al. Seventeen years of haemovigilance in France: assessment and Outlook. Transfus Clin Biol 2011; 18:140-50
19 CARREL T, ENGLBERGER L. Coronary bypass surgery in patients treated with clopidogrel. Is it safe? Curr Opin Cardiol 2009; 24:539-43
20 CARSON JL, ALTMAN DG, DUFF A, et al. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999; 39:694-700
21 CARSON JL, DUFF A, POSES RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996; 348:1055-60
22 CARSON JL, GROSSMAN BJ, KLEINMAN S, et al. Red blood cell transfusion: A clinical practice guideline from the AABB. Ann Intern Med 2012; 157:49-58
23 CARSON JL, KURIYAN M. What should trigger a transfusion ? Transfusion 2010; 50:2073-5
24 CARSON JL, NOVECK H, BERLIN JA, GOULD SA. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 2002; 42:812-8
25 CARSON JL, TERRIN ML, MAGAZINER J. Anemia and postoperative rehabilitation. Can J Anaesth 2003; 50:S60-4
26 CARSON JL, TERRIN ML, NOVECK H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365:2453-62
27 CASTILLO JJ, DALIA S, PASCUAL SK. Association between red blood cell transfusions and development of non-Hodgkin lymphoma: a meta-analysis of observational studies. Blood 2010; 116:2897-907
28 CHASSOT PG, MARCUCCI C, DELABAYS A, SPAHN DR. Perioperative antiplatelet therapy. Am Fam Physician 2010; 82:1484-9
29 CHELEMER SB, PRATO BS, COX PM, et al. Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery. Ann Thorac Surg 2002; 73:138-42
30 COLEMAN CI, RIGALI VT, HAMMOND J, et al. Evaluating the safety implications of aprotinin use: The retrospective evaluation of aprotinin in cardio-thoracic surgery (REACTS). J Thor Cardiovasc Surg 2007; 133:1547-52
31 CORTET M, DENEUX-THARAUX C, DUPONT C, et al. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth 2012; 108:984-9
32 CORWIN HL, GETTINGER A, PEARL RG, et al. The CRIT study: Anemia and blood transfusion in the critically ill – Current clinical practice in the United States. Crit Care Med 2004; 32:39-52
33 COTTON BA, AU BK, NUNEZ TC, et al. Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma 2009; 66:41-9
34 CROMHEECKE S, LORSOMRADEE S, VAN DER LINDEN PJ, et al. Moderate acute isovolemic hemodilution alters myocardial function in patients with coronary artery disease. Anesth Analg 2008; 107:1145-52
34a CURLEY GF, SHEHATA N, MAZER CD, et al. Transfusion triggers for guiding RBC transfusion for cardiovascular surgery: a systematic review and meta-analysis. Crit Care Med 2014; 42:2611-24
35 CURRY N, DAVIS PW. What’s new in resuscitation strategies for the patient with multiple trauma? Injury Int J Care Injured 2012; 43:1021-8
35a DE ALMEIDA JP, VINCENT JL, GALAS FR, et al. Transfusion requirements in surgical oncology patients: a prospective randomized controlled trial. Anesthesiology 2015; 122:29-38
36 DEFOE GR, ROSS CS, OLMSTEAD EM, et al. Northern New England Cardiovascular Disease Study group: Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Ann Thorac Surg 2001; 71:769-76
37 DENAULT A, DESCHAMPS A, MURKIN JM. A proposed algorithm for the intraoperative use of cerebral near-infrared spectroscopy. Semin Cardiothorac Vasc Anesth 2007; 11:274-81
38 DIETRICH W, BUSLEY R, SPANNAGL M, et al. The influence of antithrombin substitution on heparin sensitivity and activation of hemostasis during coronary artery bypass graft surgery : a dose-finding study. Anesth Analg 2013 ; 116 :1223-30
39 DIPROSE P, HERBERTSON MJ, O’SHAUGHNESSY, et al. Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra.operative cell salvage. Br J Anaesth 2005; 94:271-8
40 DOUKETIS JD. Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach. Blood 2011; 117:5044-9
40a DOUKETIS JD, HEALEY JS, BRUECKMANN M, et al. Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery ot procedure. Thromb Haemost 2015 ; 113:625-32
41 DOUKETIS JD, SPYROPOULOS AC, SPENCER FA, et al. Perioperative management of antithrombotic therapy : Antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest 2012 ;141(2 suppl) : e326S-50S
42 DUNNING J, VERSTEEGH M, FABBRI A, et al. Guidelines on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 2008; 34:73-92
43 ENGELBRECHT S, WOOD EM, COLE-SINCLAIR MF. Clinical transfusion practice update: haemovigilance, complications, patient blood management and national standards. Med J Aust 2013; 199:397-401
44 ENGOREN MC, HABIB RH, ZACHARIAS A, et al. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 2002; 74:1180-6
45 ETCHASON J, PETZ L, KEELER E, et al. The cost effectiveness of preoperative autologous blood donation. N Engl J Med 1995; 332:719-24
46 FARRUGIA A. Falsification or paradigm shift ? Toward a revision of the common sense of transfusion. Transfusion 2011; 51:216-24
47 FERGUSSON DA, HEBERT PC, MAZER CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358:2319-32
48 FERGUSSON DA, HUTTON B, MANIATIS A, et al. Use of recumbinant human erythropoietin in orthopaedic surgery: a systematic review. 2012; 00:00-00.
49 FERNANDEZ CJ, AKAMINE N, DEMARCO FV, et al. Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients. Crit Care 2001; 5:362-7
50 FERNANDEZ MC, GOTTLIEB M, MENITOCE JE. Blood transfusion and postoperative infection in orthopaedic patients. Transfusion 1992; 32:318-22
51 FERRARIS VA, BROWN JR, DESPOTIS GJ, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91:944-82
52 FERRARIS VA, DAVENPORT DL, SAHA SP, et al. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg 2012; 147:49-55
53 FINTEL DJ. Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options. Vasc Health Risk Manag 2012; 8:77-89
54 FITZGERALD RD, MARTIN CM, DIETZ GE, et al. Transfusing red blood cells stored in citrate phosphate dextrose adenine-1 for 28 days failed to improve tissue oxygenation in rats. Crit Care Med 1997; 25:726-32
55 FLYNN EP, AUER RN. Eubaric hyperoxemia and experimental cerebral infarction. Ann Neurol 2002; 52:566-72
55a FOMINSKIY E, PUTZU A, MONACO F, et al. Liberal transfusion strategy improves survival in perioperative but not critically ill patients. A meta-analysis of randomised trials. Br J Anaesth 2015; 115:511-9
56 FRANK SM, ABAZYAN B, ONO M, et al. Decreased erythrocyte deformability after transfusion and the effects of erythrocyte storage duration. Anesth Analg 2013; 116:975-81
57 FRANK SM, SAVAGE WJ, ROTSCHILD JA, et al. Variability in blood and blood component utilization as assessed by an anesthesia information management system. Anesthesiology 2012; 117:99-106
58 FREISCHLAG JA. Intraoperative blood salvage in vascular surgery – worth the effort ? Critical Care 2004; 8(Suppl 2):S53-6
59 FRIES D, MARTINI WZ. The role of fibrinogen in trauma induced coagulopathy (TIC). Br J Anaesth 2010; 105:116-21
60 GARCIA DA, BAGLIN TP, WEITZ JI, et al. Parenteral anticoagulants: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (Suppl 2):e24S-e43S
61 GLANCE LG, DICK AW, MUKAMEL DB, et al. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 2011; 114:283-92
62 GOGARTEN W, VANDERMEULEN E, VAN AKEN H, et al. Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol 2010; 27:999-1015
63 GOODNOUGH LT. Iron deficiency syndromes and iron.-restricted erythropoiesis. Transfusion 2012; 52:1584-92
64 GOODNOUGH LT. The use of erythropoietin to increase red cell mass. Can J Anaesth 2003; 50:S10-8
65 GOODNOUGH LT, MANIATIS A, EARNSHAW P, et al. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 2011; 105:13-22
66 GOODNOUGH LT, SHANDER A. Current status of pharmacologic therapies in patient blood management. Anesth Analg 2013 ; 116 : 15-34
67 GÖRLINGER K, DIRKMANN D, HANKE AA, et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 2011; 115:1179-91
68 GÖRLINGER K, DIRKMANN D, HANKE AA. Potential value of transfusion protocols in cardiac surgery. Curr Opin Anaesthesiol 2013; 26:230-43
68a GREGERSEN M, BORRIS LC, DAMSGAARD EM. Postoperative blood transfusion strategy in frail, anemic elderly patients with hip fracture: the TRIFE randomized controlled trial. Acta Orthop 2015; 86:363-72
69 GURALNIK JM, FERRUCCI L, SIMONSICK EM, et al. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995; 332:556-61
70 HABIB RH, ZACHARIAS A, SCHWANN TA, et al. Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: Implications on operative outcome. Crit Care Med 2005; 33:1749-56
71 HABLER OP, KLEEN MS, HUTTER JW, et al. Effects of hyperoxic ventilation on hemodilution-induced changes in anesthetized dogs. Transfusion 1998; 38:135-44
72 HAJJAR LA, VINCENT JL, GALAS FRB, et al. Transfusion requirements after cardiac surgery. The TRACS randomized controlled trial. JAMA 2010 ; 304 ;1559-67
73 HALL R, MAZER CD. Antiplatelet drugs: A review of their pharmacology and management in the perioperative period. Anesth Analg 2011; 112:292-318
74 HANNAN EL, SAMADASHVILI Z, LAHEY SS, et al. Predictors of postoperative hematocrit and association of hematocrit with adverse outcomes for coronary artery bypass graft surgery patients with cardioplmonary bypass. J Card Surg 2010 ; 25 :638-46
75 HARROP-GRIFFITHS W, COOK T, GILL H, et al. Regional anaesthesia and patients with abnormalities of coagulation. The Association of Anaesthetists of Great Britain & Ireland, the Obstetric Anaesthetists’ Association. Anaesthesia 2013; 68:966-72
76 HAWN MT, GRAHAM LA; RICHMAN JS, et al. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA 2013; 310:1462-72
77 HEBERT PC, FERGUSSON D, BLAJCHMAN MA, et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA 2003; 289:1941-9
78 HEBERT PC, WELLS G, BLAJCHMAN MA, et al. Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999; 340:409-17
79 HEBERT PC, VAN DER LINDEN P, BIRO G, HU LQ. Physiologic aspects of anemia. Crit Care Clin 2004; 20:187-212
80 HENDRICKSON JE, HILLYER CD. Noninfectious serious hazards of transfusion. Anesth Analg 2009; 108:759-69
81 HEWITT PE, LLEWELYN CA, MACKENZIE J, et al. Creutzfeldt-Jakob disease and blood transfusion: results of the UK transfusion medicine epidemiological review study. Vox Sanguinis 2006; 91:221-30
82 HILL GE, FRAWLEY WH, GRIFFITH KE, et al. Allogeneic blood transfusion increases the risk of postoperative bacterial infections: A meta-analysis. J Trauma 2003; 54:908-14
83 HILLYER CD, LANKFORD KV, ROBACK JD, et al. Transfusion of the HIV-positive patient: Immunomodulation, viral reactivation, and limiting exposure to EBV, CMV, and HHV-6, 7, and 8. Transfusion Med Rev 1999; 13:1-10
84 HO J, SIBBALD WJ, CHIN-YEE IH. Effects of storage on efficacy of red cell transfusion: When is it not safe ? Crit Care Med 2003; 31:(Suppl):S687-97
85 HOGUE CW, GOODNOUGH LT, MONK TG. Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy. Transfusion 1998; 38:924-31
86 HOLCOMB JB, GUMBERT S. Potential value of protocols in substantially bleeding trauma patients. Curr Opin Anaesthesiol 2013; 26:215-20
87 HOVAV T, YEDGAR S, MANNY N, et al. Alteration of red cell aggregability and shape during blood storage. Transfusion 1999; 39:277-81
88 INABA K, BRANCO BC, RHEE P, et al. Impact of plasma transfusion in trauma patients who do not require massive transfusion. J Am Coll Surg 2010; 210:957-65
89 INNERHOFER P, WESTERMANN I, TAUBER H, et al. The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury 2013; 44:209-16
90 IRISH CL, MURKIN JM, CLELAND A, et al. Neuromuscular blocked significantly decreases systemic oxygen consumption during hypothermic cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1991; 5:132-4
91 ISBISTER JP, SHANDER A, SPAHN DR, et al. Adverse blood transfusion outcomes: establishing causation. Transf Med Rev 2011; 25:89-101
92 JAMES AH, PAGLIA MJ, GERNSHEIMER T, et al. Blood component therapy in postpartum hemorrhage. Transfusion 2009; 49:2430-3
93 JAMNICKI M, KOCIAN R, VAN DER LINDEN P, ZAUGG M, SPAHN DR. Acute normovolemic hemodilution: Physiology, limitations and clinical use. J Cardiothorac Vasc Anesth 2003; 17:747-54
94 KAO DP, KRESO E, FONAROW GC, et al. Characteristics and outcomes among heart failure patients with anemia and renal insuficiency with and without blood transfusions. Am J Cardiol 2011; 107:69-73
95 KAPETANAKIS EI, MEDLAM DA, BOYCE SW, et al. Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist’s panacea or the surgeon’s headache? Eur Heart J 2005; 26: 576-83
96 KARKOUTI K, BEATTIE WC, DATTILO KM, et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 2006; 46:327-38
97 KARKOUTI K, Djaiani G, Borger MA, et al. Low hematocrit during cardiopulmonary bypass is associated with increased risk of perioperative stroke in cardiac surgery. Ann Thorac Surg 2005; 80:1381-7
97a KARKOUTI K, McCLUSKEY SA, CALLUM J, et al. Evaluation of a novel transfusion algorithm employing point-of-care coagulation assays in cardiac surgery. Anesthesiology 2015; 122:560-70
98 KARKOUTI K, VON HEYMANN C, JESPERSEN CM, et al. Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: A randomized, placebo-controlled, multicenter clinical trial. J Thorac Cardiovasc Surg 2013; 146:927-39
99 KARKOUTI K, WIJEYSUNDERA DN, BEATTIE S, et al. Risk associated with preoperative anaemia in cardiac surgery. A multicenter cohort study. Circulation 2008; 117:478-84
100 KARKOUTI K, WIJEYSUNDERA DN, YAU TM, et al. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery. Anesth Analg 2010; 110:21-9
101 KARKOUTI K, WIJEYSUNDERA DN, YAU TM, et al. Influence of erythrocyte transfusion on the risk of acute kidney injury after cardiac surgery differs in anemic and nonanemic patients. Anesthesiology 2011; 115:523-30
102 KASHUK JL, MOORE EE, JOHNSON JL, et al. Postinjury lifethreatening coagulopathy: is 1:1 fresh frozen plasma:packed red blood cells the answer? J Trauma 2008; 65:261-70
103 KER K, EDWARDS P, PEREL P, et al. Effects of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012; 344:e3054
104 KLEIN HG. Immunomodulatory aspects of transfusion. Anesthesiology 1999; 91:861-5
105 KOCH CG, LI L, DUNCAN AI, et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 2006; 81:1650-7
106 KOCH CG, LI L, SESSLER DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358:1229-39
107 KOR DJ, STUBBS JR, GAJIC O. Perioperative coagulation management – fresh frozen plasma. Best Pract Res Clin Anaesthesiol 2010; 24: 51-64
108 KORTE W, CATTANEO M, CHASSOT PG, et al. Perioperative management of antiplatelet therapy in patients with coronary artery disease. Thromb Haemost 2011; 105: 743-9
109 KOSMADAKIS N, MESSARIS E, MARIS A, et al. Perioperative erythropoietin administration in patients with gastrointestinal tract cancer: Prospective randomized double-blind study. Ann Surg 2003; 237:417-21
110 KOZEK-LANGENECKER SA, AFSHARI A, ALBALADEJO P, et al. Management of severe perioperative bleeding. Guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30:270-382
111 KOZEK-LANGENECKER S, SORENSEN B, HESS JR, SPAHN DR. Clinical effectiveness of fresh-frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care 2011; 15:R239
112 KULIER A, LEVIN J, MOSER R, et al. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass surgery. Circulation 2007; 116:471-9
112a LACROIX J, HEBERT PC, FERGUSSON DA; et al. Age of transfused blood in critically ill adults. N Engl J Med 2015; 372:1410-8
113 LAXENAIRE MC, DEWACHTER P, PECQUET C. Le risque allergique de l’aprotinine. Ann Fr Anesth Réanim 2000; 19:96-104
114 LEAL-NOVAL SR, RINCON-FERRARI MD, GARCIA-CURIEL A, et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 2001; 119:1461-8
115 LEAL-NOVAL SR, JARA-LOPEZ I, GARCIA-GARMENDIA JL, et al. Influence of erythrocyte concentrate storage time on postsurgical morbidity in cardiac surgery patients. Anesthesiology 2003; 98:815-22
115a LEAL-NOVAL SR, MUÑOZ-GOMEZ M, JUMENEZ-SANCHEZ M, et al. Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit ? Intensive Care Med 2013; 39:45-53
116 LEUNG JM, WEIKOPF RB, FEINER J, et al. Electrocardiographic ST-segment changes during acute, severe isovolemic hemodilution in humans. Anesthesiology 2000; 93:1004-10
117 LEVI A, CROMHEECKE ME, DE JONGE E, et al. Blood loss in cardiac surgery: a meta-analysis of clinical relevant endpoints. Lancet 1999; 354:1940-7
118 LEVI M, LEVY JH, ANDERSEN HF, et al. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010 ; 363 : 1791-800
119 LEVY J, NOVEL Pharmacologic approaches to reduce bleeding. Can J Anaesth 2003; 50:S26-30
120 LEVY JH, SZLAM F, TANAKA K, SNIECIENSKI RM. Fibrinogen and hemostasis: A primary hemostatic target for the management of acquired bleeding. Anesth Analg 2012; 114:261-74
121 LICKER M, ELLENBERGER C, SIERRA J, et al. Cardioprotective effects of acute normovolemic hemodilution in patients undergoing coronary artery bypass surgery. Chest 2005; 128:838-47
122 LICKER M, ELLENBERGER C, SIERRA J, CHRISTENSON J, et al. Cardiovascular response to acute normovolemic hemodilution in patients with coronary artery diseases: Assessment with transesophageal echocardiography. Crit Care Med 2005; 33:591-7
123 LIEBERMAN JA, WEISKOPF RB, KELLEY SD, et al. Critical oxygen delivery in conscious humans is less than 7.3 ml O2 x kg-1 x min-1. Anesthesiology 2000; 92:407-13
124 LIN DM, LIN ES, TRAN MH. Efficacy and sefety of erythroproietin and intravenous iron in perioperative blood management: A systematic review. Transfus Med Rev 2013; 27:221-34
125 LIUMBRUNO G, BENNARDELLO F, LATTANZIO A, et al. Recommendations for the transfusion of plasma and platelets. Blood Transfus 2009; 7:132-50
126 MALONE DL, DUNNE J, TRACY K, et al. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 2003; 54:898-907
127 MANGANO DT, TUDOR I, DIETZEL C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006; 354:353-65
128 MANGANO DT, MIAO Y, VUYLSTEKE A, et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 2007; 297:471-9
129 MARCUCCI C, MADJDPOUR C, SPAHN DR. Allogeneic blood transfusions: benefit, risks and clinical implications in countries with a low or high human development index. Brit Med Bull 2004; 70:15-28
130 MARIK PE, SIBBALD WJ. Effect of stored blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993; 269:3024-9
131 MARTIN K, KNORR J, BREUER T, et al. Seizures after open-heart surgery: Comparison of -aminocaproid acid and tranexamic acid. J Cardiothorac Vasc Anesth 2011; 26:20-5
132 MARTIN K, WIESNER G, BREUER T, et al. The risks of aprotinin and tranexamic acid in cardiac surgery: A one-year follow-up of 1188 consecutive patients. Anesth Analg 2008; 107:1783-90
133 MATOT I, SCHEININ O, JURIM, et al. Effectiveness of acute normovolemic hemodilution to minimize allogeneic blood transfusion in major liver resections. Anesthesiology 2002; 97:794-800
134 McINTYRE L, HEBERT PC, WELLS G, et al. Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients ? J Trauma 2004; 57:563-8
135 McKENNY M, RYAN T, TATE H, et al. Age of transfused blood is not associated with increased postoperative adverse outcome after cardiac surgery. Br J Anaesth 2011; 106: 643-9
136 McLINTOCK C, JAMES AH. Obstetric hemorrhage. J Thromb Haemost 2011; 9:1441-51
137 McMULLAN V, ALSTON RP. Aprotinin and cardiac surgery : a sorry tale of evidence misused. Br J Anaesth 2013 ; 110 : 675-8
138 MEIER J, Kemming GI, Kisch-Wedel H, et al. Hyperoxic ventilation reduces 6-hour mortality at the critical hemoglobin concentration. Anesthesiology 2004; 100:70-6
139 MICHLIG C, VU DH, WASSERFALLEN JB, et al. Three years of haemovigilance in a general university hospital. Transfus Med 2003; 13:63-72
140 MONK TG. Acute normovolemic hemodilution. Anesthesiol Clin N Am 2005; 32:271-81
141 MONK TG, GOODNOUGH LT, BRECHER ME, et al. A prospective, randomized trial of three blood conservation strategies for radical prostatectomy. Anesthesiology 1999; 91:24-33
142 MOSKOWITZ DM, McCULLOUGH JN, SHANDER A, et al. The impact of blood conservation on outcomes in cardiac surgery: is it safe and effective ? Ann Thorac Surg 2010; 90:451-9
143 MUDUMBAI SC, CRONKITE R, HU KU, et al. Association of admission hematocrit with 6-month and 1-year mortality in intensive care unit patients. Transfusion 2011; 51:2148-59
143a MUÑOZ M, GOMEZ-RAMIREZ S, KOZEK-LANGENEKER S, et al. “Fit-to-fly”: overcoming barriers to preoperative haemoglobin optimization in surgical patients. Br J Anaesth 2015; 115:15-24
144 MURAD MH, STUBBS JR, GANDHI MJ, et al. The effect of plasma transfusion on morbidity and mortality : a systematic review and meta-analysis. Transfusion 2010 ; 50 : 1370-83
145 MURKIN JM, FALTER F, GRANTON J, et al. High dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 2010; 110:350-3
145a MURPHY GJ, PIKE K, ROGERS CA, et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 2015; 372:997-1008
146 MURPHY GJ, REEVES BC, ROGERS CA, et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007; 116:2544-52
147 MUSALLAM KM, TAMIM HM, RICHARDS T, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011; 378:1396-407
148 NA HS, SHIN SY, HWANG JY, et al. Effects of intravenous iron combined with low-dose recombinant human reythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. Transfusion 2011; 51:118-24
149 NALLA BP, FREEDMAN J, HARE GMT, MAZER CD. Update on blood conservation for cardiac surgery. J Cardiothorac Vasc Anesth 2012; 26:117-33
150 NAPOLITANO LM, CORWIN HL. Efficacy of red blood cell transfusion in the critically ill. Crit Care Clin 2004; 20:255-68
151 NAPOLITANO LM, KUREK S, LUCHETTE FA, et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med 2009; 37:3124-57
152 NELSON AH, FLEISHER LA, ROSENBAUM SH. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med 1993; 21:860-6
153 NGAAGE DL, BLAND JM. Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent ? Meta-analysis of randomized and large matched observational studies. Eur J Cardiothorac Surg 2010; 37:1375-83
154 NUTALL GA, BROST BC, CONNIS RT, et al. Practice guidelines for perioperative blood transfusion and adjuvant therapies. Anesthesiology 2006; 105:198-208
155 OFFNER PJ, MOORE EE, BIFFL WL, et al. Increased rate of infection associated with transfusion of old blood after severe injury. Arch Surg 2002; 137:711-7
156 OKUYAMA N, YAMAGUCHI M, OKA S, et al. Preoperative iron supplementation and intraoperative transfusion during colorectal cancer surgery. Surg Today 2005; 35:36-40
157 OLSEN MA, LOCK-BUCKLEY P, HOPKINS D, et al. The risk factors for deep and superficial chest surgical-site infections after coronary artery bypass graft surgery are different. J Thorac Cardiovasc Surg 2002; 124:136-45
158 PHILLIPS LE, McLINTOCK C, POLLOCK W, et al. Recombinant activated factor VII in obstetric hemorrhage: expériences from the Australian and New Zealand Haemostasis Registry. Anesth Analg 2009; 109:1908-15
159 RAHE-MEYER N, SOLOMON C, HANKE A, et al. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology 2013; 118:40-50
160 RANUCCI M, BALDUINI A ; DITTA A, et al. A systemtaic review of biocompatible cardiopulmonary bypass circuits and clinical outcome. Ann Thorac Surg 2009 ; 87 :1311-9
161 RAO SV, JOLLIS JG, HARRINGTON RA, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004; 292:1555-62
162 REITER RA, MAYR F, BLAZICEK H, et al. Desmopressin antagonizes the in vitre platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. Blood 2003; 102:4594-9
163 ROBACK JD, CALDWELL S, CARSON J, et al. Evidence-based practice guidelines for plasma transfusion. Transfusion 2010; 50:1227-39
164 ROBERTSON HT, HALEY NR, GUTHRIE M, et al. Recombinant erythropoietin improves exercice capacity in anemic hemodialysis patients. Am J Kidney Dis 1990; 15:325-32
164a ROMAN PEF, DE VORE AD, WELSBY IJ. Techniques and applications of perioperative therapeutic plasma exchange. Curr Opin Anaesthesiol 2014; 27:57-64
165 RUCKER J, TESLER J, FEDORKO L, et al. Normocapnia improves cerebral oxygen delivery during conventional oxygen therapy in carbon-monoxyde exposed research subjects. Ann Emerg Med 2002; 40:611-8
165a SAAGER L, TURAN A, DALTON JE, et al. Erythrocyte storage duration is not associated with oncreased mortality in noncardiac surgical patients. Anesthesiology 2013; 118:51-8
166 SANDER M, SPIES CD, MARTINY V, et al. Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis. Critical Care 2010; 14:R148
167 SCHÖCHL H, NIENABER U, MAEGELE M, et al. Transfusion in trauma: thromboelastograpy-guided coagulation factor concentrate-based therapy versus standard fresh-frozen plasma-based therapy. Crit Care 2011; 15:R83
168 SEGAL JB, BLASCO-COLMENARES E, NORRIS JE, GUALLAR E. Preoperative acute normovolemic hemodilution: a meta-analysis. Transfusion 2004; 44:632-44
169 SHAKUR H, ROBERTS I, BAUTISTA R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376:23-32
170 SHANDER A, FINK A, JAVIDROOZI M, et al. Appropriateness of allogeneic red blood cell transfusion: the International Concensus Conference on Transfusion Outcomes. Transf Med Rev 2011; 25:232-46
171 SHANDER A, HOFMAN A, GOMBOTZ H, et al. Estimating the cost of blood: past, present, and future directions. Best Pract Res Clin Anaesthesiol 2007; 21:271-89
172 SHANDER A, HOFMAN A, OZAWA S, et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50:753-65
173 SHANDER A, JAVIDROOZI M. Strategies to reduce the use of blood products: a US perspective. Curr Opin Anaesthesiol 2012; 25:50-8
174 SHANDER A, JAVIDROOZI M, OZAWA S, HARE GMT. What is really dangerous: anaemia or transfusion ? Br J Anaesth 2011; 107(S1):i41-i59
175 SHANDER A, VAN AKEN H, COLOMINA MJ, et al. Patient blood management in Europe. Br J Anaesth 2012; 109:55-68
176 SHORR AF, DUH MS, KELLY KM, et al. Red blood cell transfusion and ventilator–associated pneumonia: A potential link ? Crit Care Med 2004; 32:666-72
177 SILLIMAN CC. Transfusion-related acute lung injury. Transfus Med Rev 1999; 13:177-86
178 SILVERBERG DS, WEXLER D, SHEPS D, et al. The effect of correction in mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: A randomized controlled study. J Am Coll Cardiol 2001; 37:1775-80
179 SPAHN DR. Anemia and patient blood management in hip and knee surgery. A systematic review analysis. Anesthesiology 2010; 113:482-95
180 SPAHN DR, BOUILLON B, CERNY V, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013; 17:R76
181 SPAHN DR, CASUTT M. Eliminating blood transfusions. Anesthesiology 2000; 93:242-55
182 SPAHN DR, DETTORI N, KOCIAN R, CHASSOT PG. Transfusion in the cardiac patient. Crit Care Clin 2004; 20:269-79
183 SPAHN DR, GANTER MT. Towards early individual goal-directed coagulation management in trauma patients. Brit J Anaesth 2010; 105:103-5
184 SPAHN DR, GOODNOUGH LT. Blood transfusion 2. Alternatives to blood transfusion. Lancet 2013; 381:1855-65
185 SPAHN DR, KORTE W. Novel oral anticoagulants. New challenges for anesthesiologists in bleeding patients. Anesthesiology 2012 ; 116 :9-11
186 SPAHN DR, LEONE BJ, REVES JG, PASCH T. Cardiovascular and coronary physiology of acute isovolemic hemodilution. A review of non-oxygen carrying and oxygen-carryinf solutions. Anesth Analg 1994; 78:1000-21
187 SPAHN DR, MOCH H, HOFMANN A, ISBISTER JP. Patient blood management: the pragmatic solution for the problem with blood transfusions. Anesthesiology 2008; 109:951-3
188 SPAHN DR, SEIFERT B, PASCH T, SCHMID ER. Haemodilution tolerance in patients with mitral valve regurgitation. Anesthesia 1998; 53:20-4
189 SPAHN DR, ZOLLINGER A, SCHLUMPF RB, et al. Hemodilution tolerance in elderly patients without known cardiac disease. Anesth Analg 1996; 82:681-6
190 SPIESS BD, ROYSTON D, LEVY JH, et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 2004; 44:1143-8
191 STANWORTH SJ, GRANT-CASEY J, LOWE D, et al. The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children. Transfusion 2011; 51:62-70
192 STEHLING L, SIMON TL. The red blood cell transfusion trigger: Physiology and clinical studies. Arch Pathol Lab Med 1994; 118:429-36
192a STEINER ME, NESS PM, ASSMANN SF, et al. Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med 2015; 372:11419-29
193 STRAMER SL, HOLLIGER FB, KATZ LM, et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 2009; 49:1S-29S
194 SUNGURTEKIN H, COOK DJ, ORSZULAK TA, et al. Cerebral response to hemodilution during hypothermic cardiopulmonary bypass in adults. Anesth Analg 1999; 89:1078-83
195 SURGENOR SD, KRAMER RS, OLMSTEAD EM, et al. The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg 2009; 108:1741-6
196 SUTTNER S, PIPER SN, KUMLE B, et al. The influence of allogeneic red blood cell transfusion compared with 100% oxygen ventilation on systemic oxygen transport and skeletal muscle oxygen tension after cardiac surgery. Anesth Analg 2004; 99:2-11
197 SWAMINATHAN M, PHILIPS-BUTE BG, CONLON PJ, et al. The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Ann Thorac Surg 2003; 76:784-91
198 TEIXIERA PGR, INABA k, SHULMAN I, et al. Impact of plasma transfusion in massively transfused trauma patients. J Trauma 2009; 66:693-7
199 THEUSINGER OM, FELIX C, SPAHN DR. Strategies to reduce the use of blood products: a European perspective. Curr Opin Anaesthesiol 2012; 25:59-65
200 THEUSINGER OM, SPAHN DR, GANTER MT. Transfusion in trauma: why and how should we change our current practice ? Curr Opin Anaesthesiol 2009; 22:305-12
201 TRIULZI DJ. Transfusion-related acute lung injury: Current concepts for the clinician. Anesth Analg 2009; 108:70-6
202 TSAI AG, CABRALES P, INTAGLIETTA M. Microvascular perfusion upon exchange transfusion with stored red blood cells in normovolemic anemic conditions. Transfusion 2004; 44:1626-34
203 TSAI AG, VANDEGRIFF KD, INTAGLIETTA M, WINSLOW RM. Targeted O2 delivery by low-P50 hemoglobin: a new basis for O2 therapeutics. Am J Physiol Heart Circ Physiol 2003; 285:H1411-9
204 TUMAN KJ. Tissue oxygen delivery: the physiology of anemia. Anesthesiol Clin North Am 1990; 8:451-63
205 UMSHEID CA, KOHL BA, WILLIAMS K. Antifibrinolytic use in adult cardiac surgery. Curr Opin Hematol 2007; 14:455-67
206 UMT/Unité de Médecine Transfusionnelle, CHUV. Rapport annuel 2009. Lausanne, 2010
207 UTTER GH, LEE TH, RIVERS RM, et al. Microchimerism decades after transfusion among combat-injured US veterans from the Vietnam, Korean and World War II conflicts. Transfusion 2008; 48:1609-15
208 VALERI CR, KHABBAZ K, KHURI SF, et al. Effect of skin temperature on platelet function in patients undergoing extracorporeal bypass. J Thorac Cardiovasc Surg 1992; 104:108-16
209 VAMVAKAS EC. Transfusion-associated cancer recurrence and postoperative infections: Meta-analysis of randomized, controlled clinical trials. Transfusion 1996; 91:861-5
210 VAMVAKAS EC. Meta-analysis of clinical studies of the purported deleterious effects of “old” (versus “fresh”) red blood cells: are we at equipoise ? Transfusion 2010; 50:600-10
211 VAMVAKAS EC, CARVEN EJ. Allogeneic blood transfusion, hospital charges, and length of hospitalization: A study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med 1998; 122:145-51
212 VAMVAKAS EC, BLAJCHMAN MA. Blood still kills: Six strategies to further reduce allogeneic blood transfusion-related mortality. Transfus Med Rev 2010; 24:77-124
213 VAN DE WATERING LMG, HERMANS J, HOUBIERS JGA, et al. Beneficial effects of leucocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: A randomized clinical trial. Circulation 1998; 97:562-8
214 VAN DE WATERING LMG, BRAND A, HOUBIERS JGA, et al. Perioperative blood transfusieons, with or without allogeneic leukocytes, relate to survival, not to cancer recurrence. Br J Surg 2001; 88:267-72
215 VAN DER LINDEN P, DE HERT S, MATHIREU N, et al. Tolerance of acute isovolemic hemodilution: Effect of anesthetic depth. Anesthesiology 2003; 99:97-104
216 VAN WERMESKERKEN GK, LARDENOYE JW, HILL SE, et al. Intraoperative physiologic variables and outcome in cardiac surgery: Part II. Neurologic outcome. Ann Thorac Surg 2000; 69:1077-83
217 VILLANUEVA C, COLOMO A, BOSCH A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368:11-21
218 VINCENT JL, BARON JF, REINHART K, et al. Anemia and blood transfusion in critically ill patients (ABC). JAMA 2002; 288:1499-507
219 VINCENT JL, SAKR Y, SPRUNG C, et al. Are blood transfusions associated with greater mortality rates ? Results of the Sepsis Occurence in Acutely Ill Patients Study. Anesthesiology 2008; 108:31-9
220 VOGT KN, VAN KOUGHNETT JA, DUBOIS L, et al. The use of trauma transfusion pathways for blood component transfusion in the civilian population: a systematic review and meta-analysis. Transf Med 2012; 22:156-66
221 WATERS JH. Red blood cell recovery and reinfusion. Anesthesiol Clin N Am 2005; 23:283-94
222 WATERS JH, LEE JS, KARAFA MT. A mathematical model of cell salvage efficiency. Anesth Analg 2002; 95:1312-7
223 WEBER CF, GÖRLINGER K, MEININGER D. Point-of-care testing : a prospective randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012 ; 117 : 531-47
224 WEBER RS, JABBOUR N, MARTIN RCG. Anemia and transfusion in patients undergoing surgery for cancer. Ann Surg Oncol 2008; 15:34-45
225 WEISKOPF RB, KRAMER JH, VIELE MK, et al. Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology 2000; 92:1646-52
226 WEISKOPF RB, FEINER J, VIELE MK, et al. Oxygen reverses deficits of cognitive function and memory and increased heart rate induced by acute severe isovolemic anemia. Anesthesiology 2002; 96:871-7
227 WEISKOPF RB, FEINER J, HOPF H, et al. Fresh blood and aged stored blood are equally efficacious in immediately reversing anemia-induced brain oxygenation deficits in humans. Anesthesiology 2006; 104:911-20
228 WELTERT L, D’ALESSANDRO S, NARDELLA S, et al. Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. J Thorac Cardiovasc Surg 2010; 139:621-7
229 WU WC, RATHORE SS, WANG Y, et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001; 345:1230-6
230 WU WC, SCHIFFTER TL, HENDERSON WG, et al. Preoperative hematocrit levels and postoperatieve outcomes in older patients undergoing noncardiac surgery. JAMA 2007; 297:2481-8
231 WU WC, SMITH TS, HENDERSON EG, et al. Operative blood loss, blood transfusion, and 30-day mortality in older patients after major noncardiac surgery. Ann Surg 2010; 252:11-7
232 YANG L, STANWORTH S, HOPEWELL S, et al. Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials. Transfusion 2012; 52:1673-86
233 YANK V, TUOHY CV, LOGAN AC, et al. Systematic review : benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Ann Intern Med 2011 ; 154 : 529-40
234 YENDE S, WUNDERINK RG. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med 2001; 29:2271-5
235 YOO YC, SHIM JK, KIM JC, et al. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperative anemic patients undergoing valvular heart surgery. Anesthesiology 2011; 115:929-37
236 ZANGRILLO A, MIZZI A, BIONDI-ZOCCAI G, et al. Recombinant activated factor VII in cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth 2009; 23:34-40

 

Références (Témoins de Jéhovah)

tj1 BENAROYO L. Ethique et responsabilité en médecine. Genève: Ed Médecine & Hygiène, 2006
tj2 CHASSOT PG, KERN C, RAVUSSIN P. Hémorragie et transfusion: le cas des Témoins de Jéhovah. Rev Méd Suisse 2006; 2(88):2674-6, 2678-9
tj3 FINFER S, HOWELL S, MILLER J, et al. Managing patients who refuse blood transfusions: an ethical dilemna. Brit Med J 1994; 308:1423-5
tj4 LORIAU J, MANAOUIL C, MONTPELLIER D, et al. Chirurgie et transfusion chez les patients témoins de Jéhovah. Mise au point médico-légale. Ann Chirurgie 2004; 129:263-8
tj5 MAYLON D. Transfusion-free treatment of Jehovah’s Witnesses: respecting the autonomous patient’s motives. J Med Ethics 1998; 24:37-81
tj6 MAYLON D. Transfusion-free treatment of Jehovah’s Witnesses: respecting the autonomous patient’s rights. J Med Ethics 1998; 24:302-7
tj7 SINGELENBERG R. The blood transfusion taboo of Jehovah’s Witness. Origin, development and function of a controversial doctrine. Social Science Med 1990; 31:515-23
tj8 VINCENT JL. Transfusion in the exsanguinating Jehovah’s Witness patient. The attitude of intensive care doctors. Eur J Anaesthesiol 1991; 8:297-300
tj9 LAWSON T, RALPH C. Perioperative Jehovah’s Witnesses : a review. Br J Anaesth 2015 ; 115 : 676-87